Neurocrine Biosciences Inc. (NBIX) reported a third quarter loss of $0.13 per share after the close Wednesday, compared to the loss of $0.43 per share last year. The consensus estimate was for a loss of $0.49 per share.
from RTT - Before the Bell http://ift.tt/2A4NGVw
via IFTTT
No comments:
Post a Comment